NeuroPace, Inc.
NPCE
$15.96
$0.332.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.02% | 23.86% | 29.89% | 22.14% | 24.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.02% | 23.86% | 29.89% | 22.14% | 24.28% |
| Cost of Revenue | -22.42% | 13.87% | 9.68% | 5.19% | 8.39% |
| Gross Profit | 4.07% | 27.12% | 37.28% | 28.29% | 29.97% |
| SG&A Expenses | 9.16% | 11.07% | 23.60% | 26.66% | -0.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.13% | 12.88% | 18.38% | 19.06% | 7.80% |
| Operating Income | -8.18% | 51.63% | 38.72% | -9.53% | 31.78% |
| Income Before Tax | -1.52% | 48.02% | 35.88% | -15.13% | 26.17% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.52% | 48.02% | 35.88% | -15.13% | 26.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.52% | 48.02% | 35.88% | -15.13% | 26.17% |
| EBIT | -8.18% | 51.63% | 38.72% | -9.53% | 31.78% |
| EBITDA | -8.04% | 53.20% | 39.19% | -9.67% | 32.03% |
| EPS Basic | 5.21% | 53.45% | 43.03% | -1.08% | 33.66% |
| Normalized Basic EPS | 5.20% | 54.67% | 43.04% | -1.04% | 33.67% |
| EPS Diluted | 5.21% | 53.45% | 43.03% | -1.08% | 33.66% |
| Normalized Diluted EPS | 5.20% | 54.67% | 43.04% | -1.04% | 33.67% |
| Average Basic Shares Outstanding | 7.10% | 11.60% | 12.53% | 13.90% | 11.30% |
| Average Diluted Shares Outstanding | 7.10% | 11.60% | 12.53% | 13.90% | 11.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |